Gal4-TEAD4 Citations (7)
Originally described in: Guan lab plasmidsUnpublished
Articles Citing Gal4-TEAD4
| Articles |
|---|
| LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap. Nguyen HB, Babcock JT, Wells CD, Quilliam LA. Oncogene. 2013 Aug 29;32(35):4100-9. doi: 10.1038/onc.2012.431. Epub 2012 Oct 1. PubMed |
| Verteporfin induces apoptosis and eliminates cancer stem-like cells in uveal melanoma in the absence of light activation. Ma YW, Liu YZ, Pan JX. Am J Cancer Res. 2016 Dec 1;6(12):2816-2830. eCollection 2016. PubMed |
| Genetic ablation of the mammalian sterile-20 like kinase 1 (Mst1) improves cell reprogramming efficiency and increases induced pluripotent stem cell proliferation and survival. Robertson A, Mohamed TM, El Maadawi Z, Stafford N, Bui T, Lim DS, Cartwright EJ, Oceandy D. Stem Cell Res. 2017 Apr;20:42-49. doi: 10.1016/j.scr.2017.02.011. Epub 2017 Feb 27. PubMed |
| Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU-MP-1, protects the heart against adverse effects during pressure overload. Triastuti E, Nugroho AB, Zi M, Prehar S, Kohar YS, Bui TA, Stafford N, Cartwright EJ, Abraham S, Oceandy D. Br J Pharmacol. 2019 Oct;176(20):3956-3971. doi: 10.1111/bph.14795. Epub 2019 Oct 8. PubMed |
| LACTB suppresses melanoma progression by attenuating PP1A and YAP interaction. Ma Y, Wang L, He F, Yang J, Ding Y, Ge S, Fan X, Zhou Y, Xu X, Jia R. Cancer Lett. 2021 May 28;506:67-82. doi: 10.1016/j.canlet.2021.02.022. Epub 2021 Mar 4. PubMed |
| USP22 promotes melanoma and BRAF inhibitor resistance via YAP stabilization. Wei Y, Jiang Z, Lu J. Oncol Lett. 2021 May;21(5):394. doi: 10.3892/ol.2021.12655. Epub 2021 Mar 18. PubMed |
| Genetic and Pharmacological YAP Activation Induces Proliferation and Improves Survival in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Bui TA, Stafford N, Oceandy D. Cells. 2023 Aug 22;12(17):2121. doi: 10.3390/cells12172121. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.